Experts, lawmakers call for improved drug pipeline to treat superbugs
Antimicrobial resistant (AMR) microorganisms, also known as superbugs, increasingly threaten every person on Earth, according to the World Health Organization (WHO) and national experts.
“Antimicrobial resistance is one of the most urgent health risks of our time and threatens to undo a century of medical progress,” said WHO Director-General Dr. Tedros Adhanom Ghebreyesus, who recently called for AMR action across all government sectors and society as new AMR microorganisms emerge and spread globally.
The problem is that AMR microorganisms — like bacteria, fungi, viruses and some parasites — stop antimicrobials — such as antibiotics, antivirals and antimalarials — from working against them, rendering standard treatments ineffective so that infections persist and then spread, resulting in prolonged illness, disability and death
Display your AMR technology / product:
Global AMR Technologies Database
- Preventive – Diagnostic – Antimicrobial technologies
- Academia – Research Institutes – Start ups – SMEs – Multinationals
- Early research <-> near market (max 5)
- Global reach for funding / co-development / licensing
- No costs (until year end 2019)
Festive Launch Database 19 Nov Symposium Dinner ‘Emerging Antimicrobials and Diagnostics in AMR 2019‘
Click to join the Symposium Dinner (to join the Symposium separate registration obligatory)